Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
The risk of atherosclerotic cardiovascular disease (ASCVD) is strongly related to lifetime exposure to low-density lipoprotein (LDL)-cholesterol in longitudinal studies. Lipid-lowering therapy (using statins, ezetimibe and PCSK9 inhibitors) substantially ameliorates the risk and is associated with l...
Saved in:
Main Authors: | Maciej Banach (Author), Alberico L. Catapano (Author), Arrigo F.G. Cicero (Author), Carlos Escobar (Author), Bernhard Foger (Author), Niki Katsiki (Author), Gustavs Latkovskis (Author), Michal Rakowski (Author), Zeljko Reiner (Author), Amirhossein Sahebkar (Author), Geeta Sikand (Author), Peter E. Penson (Author), on behalf of the International Lipid Expert Panel (ILEP) (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
European guidelines for the treatment of dyslipidaemias: New concepts and future challenges
by: Angela Pirillo, et al.
Published: (2023) -
Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
by: Peter E. Penson, et al.
Published: (2022) -
New Therapeutic Approaches in Treatment of Dyslipidaemia-A Narrative Review
by: Iveta Merćep, et al.
Published: (2022) -
Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI studyResearch in context
by: Julia Brandts, et al.
Published: (2023) -
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023)